ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 1456

$1.17M Total Retail Price of All Prescriptions

Rank: 74 out of 1456

1,006 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,006 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

23% of this provider’s 1,006 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 18,617 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,179 865 S3 1 6
SIMVASTATIN 937 735 2 2
AMLODIPINE BESYLATE 890 674 3 1
FUROSEMIDE 815 676 4 7
LISINOPRIL 738 556 5 3
LEVOTHYROXINE SODIUM 693 548 6 4
METFORMIN HCL 609 444 7 8
OMEPRAZOLE 563 378 8 5
METOPROLOL TARTRATE 455 367 9 12
POTASSIUM CHLORIDE 453 263 10 15
GABAPENTIN 432 282 11 13
TRAMADOL HCL 389 273 12 17
CITALOPRAM HBR 361 272 13 22
ZOLPIDEM TARTRATE 343 235 14 14
BENAZEPRIL HCL 265 198 15 57
SERTRALINE HCL 263 154 16 25
CARVEDILOL 257 168 17 20
RANITIDINE HCL 249 181 18 27
WARFARIN SODIUM 234 180 19 21
FAMOTIDINE 230 163 20 45
DONEPEZIL HCL 229 211 21 29
MELOXICAM 218 160 22 30
PRAVASTATIN SODIUM 216 172 23 9
METOPROLOL SUCCINATE 204 174 24 19
NAMENDA 198 197 25 38
NEXIUM 191 106 26 23
CLOPIDOGREL 186 139 27 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 185 123 28 24
TAMSULOSIN HCL 180 132 29 34
HYDROCHLOROTHIAZIDE 175 100 30 10
CLONIDINE HCL 163 117 31 39
DIOVAN 162 107 32 35
RISPERIDONE 160 130 33 72
ALLOPURINOL 159 115 34 31
ATORVASTATIN CALCIUM 151 118 35 11
CELEBREX 146 134 36 88
ALBUTEROL SULFATE 144 100 37 136
ADVAIR DISKUS 144 88 37 63
AMITRIPTYLINE HCL 140 99 R 39 70
MIRTAZAPINE 138 128 40 65
ATENOLOL 138 120 40 18
VERAPAMIL ER 134 104 42 82
TRAZODONE HCL 132 71 43 47
LYRICA 132 64 43 91
ISOSORBIDE MONONITRATE ER 131 117 45 60
FLUTICASONE PROPIONATE 131 79 45 28
LOSARTAN POTASSIUM 130 109 47 16
FLUOXETINE HCL 128 72 48 55
JANUVIA 124 56 49 68
DIGOXIN 122 116 50 62
ALENDRONATE SODIUM 121 111 51 36
GLIMEPIRIDE 120 97 52 33
CYCLOBENZAPRINE HCL 119 52 R 53 66
PLAVIX 118 86 54 46
PROMETHAZINE HCL 117 65 R 55 77
OXYBUTYNIN CHLORIDE ER 116 87 56 167
ROPINIROLE HCL 116 83 56 90
GLIPIZIDE XL 114 58 58 134
DILTIAZEM ER 113 102 59 147
PREDNISONE 112 93 60 42
AMLODIPINE BESYLATE-BENAZEPRIL 110 100 61 61
PAROXETINE HCL 108 88 62 67
ZOSTAVAX 105 87 63 187
COMBIVENT 102 60 64 110
TRIAMTERENE-HCTZ 101 69 65 49
SPIRONOLACTONE 101 60 65 73
TERAZOSIN HCL 96 89 67 142
PROAIR HFA 90 50 68 69
INSULIN SYRINGE 89 72 69 64
MEGESTROL ACETATE 87 73 R 70 179
PHENYTOIN SODIUM EXTENDED 85 37 71 128
LOSARTAN-HYDROCHLOROTHIAZIDE 85 72 71 41
TRAMADOL HCL-ACETAMINOPHEN 85 72 71 139
BYSTOLIC 84 71 74 102
KLOR-CON M20 83 47 75 51
MECLIZINE HCL 83 78 75 101
CARISOPRODOL 83 0 R 75 80
LANTUS 81 79 78 50
COLCRYS 79 59 79 122
FENOFIBRATE 79 66 79 56
DILTIAZEM 24HR CD 77 76 81 159
AVODART 76 54 82 218
HUMULIN 70-30 76 65 82 205
EXELON 75 75 84 105
DIOVAN HCT 75 71 84 59
TRIAMCINOLONE ACETONIDE 74 61 86 158
AZITHROMYCIN 74 59 86 44
PANTOPRAZOLE SODIUM 73 52 88 43
HYDRALAZINE HCL 71 38 89 48
NITROGLYCERIN PATCH 71 57 89 178
NOVOLIN R 70 44 91 133
METOCLOPRAMIDE HCL 70 47 91 125
DILTIAZEM 24HR ER 69 57 93 126
LIPITOR 69 38 93 76
RAMIPRIL 69 68 93 98
LOVASTATIN 68 56 96 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 47 96 107
CYMBALTA 68 26 96 52
BENZTROPINE MESYLATE 68 48 R 96 222
GLIPIZIDE ER 67 65 100 86
TRIAMTERENE-HYDROCHLOROTHIAZID 63 57 101 201
QUETIAPINE FUMARATE 63 47 101 78
CEFUROXIME 61 41 103 138
NOVOLIN 70-30 59 36 104 144
NAPROXEN 59 32 104 100
CIPROFLOXACIN HCL 58 39 106 58
FINASTERIDE 57 51 107 110
CARBIDOPA-LEVODOPA 57 49 107 141
TRICOR 56 22 109 92
FENTANYL 54 47 S2 110 114
SPIRIVA 54 24 110 75
SINGULAIR 54 39 110 83
GLYBURIDE-METFORMIN HCL 54 49 R 110 119
PREMARIN 53 52 R 114 99
QUINAPRIL HCL 52 51 115 155
SUCRALFATE 51 29 116 171
ESCITALOPRAM OXALATE 51 42 116 74
PENTOXIFYLLINE 50 23 118 322
HYDROXYZINE HCL 50 27 R 118 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.